Skip to main content
Contact Us
Subscribe
E-Edition
63°
Site search
Search
Menu
Open user controls
Log In Using Your Account
Log In
Don't have an account?
Sign Up Today
My Account
Dashboard
Profile
Saved items
Logout
Home
About Us
Contact Us
Advertise
Terms and Conditions
Privacy Policy
Home Delivery
Subscription Services
Place an Ad
Promote Your Event
Local Weather
News
Sports
Obits
Multimedia
Photo Galleries
Videos
e-Edition
Classifieds
Real Estate
Property For Rent
Cars & Vehicles
Jobs
Items For Sale
Pets
Auctions, Estate & Garage Sales
Services
Community
Personals
Place An Ad
Subscribe
Archives
Best of 2025
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Privia Health Group, Inc. - Common Stock
(NQ:
PRVA
)
25.02
UNCHANGED
Streaming Delayed Price
Updated: 4:00 PM EDT, May 9, 2025
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Privia Health Group, Inc. - Common Stock
< Previous
1
2
3
4
Next >
JP Morgan Maintains Overweight Rating for Privia Health Gr: Here's What You Need To Know
March 06, 2024
Via
Benzinga
Forecasting The Future: 4 Analyst Projections For Privia Health Gr
February 29, 2024
Via
Benzinga
Earnings Scheduled For February 27, 2024
February 27, 2024
Companies Reporting Before The Bell • Gaotu Techedu (NYSE:GOTU) is expected to report quarterly loss at $0.07 per share on revenue of $100.49 million.
Via
Benzinga
Privia Health Gr's Earnings: A Preview
February 26, 2024
Via
Benzinga
B of A Securities Downgrades Privia Health Gr: Here's What You Need To Know
February 22, 2024
Via
Benzinga
Why Panbela Therapeutics Shares Are Trading Lower By 65%? Here Are Other Stocks Moving In Monday's Mid-Day Session
January 29, 2024
Shares of Panbela Therapeutics, Inc. (NASDAQ: PBLA) fell sharply during Monday’s session after the company announced pricing of a roughly $9 million public offering. Panbela Therapeutics shares dipped...
Via
Benzinga
Preview: Privia Health Gr's Earnings
November 02, 2023
Via
Benzinga
4 Analysts Have This to Say About Privia Health Gr
August 18, 2023
Via
Benzinga
Expedia Group, Gartner, Cloudflare, Cardinal Health And Other Big Stocks Moving Higher On Friday
November 03, 2023
U.S. stocks traded higher, with the Dow Jones gaining around 200 points on Friday. Here are some big stocks recording gains in today’s session.
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Why Novonix Shares Are Trading Higher By 27%? Here Are Other Stocks Moving In Friday's Mid-Day Session
September 15, 2023
Gainers MSP Recovery, Inc. (NASDAQ: LIFW) shares jumped 127.8% to $0.1269. The company recently reported second-quarter results.
Via
Benzinga
Earnings Scheduled For August 3, 2023
August 03, 2023
Companies Reporting Before The Bell • Cedar Fair (NYSE:FUN) is likely to report quarterly earnings at $1.10 per share on revenue of $512.74 million.
Via
Benzinga
Looking Into Privia Health Gr's Return On Capital Employed
May 12, 2023
Via
Benzinga
Privia Health Gr: Q1 Earnings Insights
May 04, 2023
Via
Benzinga
Earnings Scheduled For November 3, 2023
November 03, 2023
Companies Reporting Before The Bell • Arcutis Biotherapeutics (NASDAQ:ARQT) is expected to report quarterly loss at $0.86 per share on revenue of $32.83 million.
Via
Benzinga
Velocity and Privia Health Enter Partnership to Embed Clinical Research Into Practice Sites
July 11, 2023
From
Velocity Clinical Research, Inc.
Via
GlobeNewswire
Earnings Preview For Privia Health Group
February 27, 2023
Via
Benzinga
Analyst Expectations for Privia Health Group's Future
February 03, 2023
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For June 13, 2023
June 13, 2023
Via
Benzinga
Carvana, Designer Brands, REV Group And Other Big Stocks Moving Higher On Thursday
June 08, 2023
U.S. stocks traded higher, with the Nasdaq Composite rising around 70 points on Thursday. Here are some big stocks recording gains in today’s session.
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For March 10, 2023
March 10, 2023
Via
Benzinga
4 Analysts Have This to Say About Privia Health Group
December 09, 2022
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For April 12, 2023
April 12, 2023
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For February 3, 2023
February 03, 2023
Via
Benzinga
Earnings Scheduled For February 28, 2023
February 28, 2023
Companies Reporting Before The Bell • Gaotu Techedu (NYSE:GOTU) is expected to report earnings for its fourth quarter.
Via
Benzinga
Target, Holley, Ferroglobe And Other Big Losers From Wednesday
November 17, 2022
U.S. stocks closed mostly lower on Wednesday, with the Nasdaq Composite dropping around 175 points. Here is the list of some big stocks recording losses in the previous session.
Via
Benzinga
BP To Rally Around 22%? Plus This Analyst Predicts $47 For YETI
November 11, 2022
Piper Sandler boosted the price target on BP p.l.c. (NYSE: BP) from $37 to $40. BP shares rose 1.9% to close at $32.95 on Thursday.
Via
Benzinga
Privia Health Stock Receives IBD Stock Rating Upgrade
October 03, 2022
On Monday, Privia Health stock saw an improvement in its IBD SmartSelect Composite Rating, upgrading to 96 from 94.
Via
Investor's Business Daily
Where Privia Health Group Stands With Analysts
September 07, 2022
Over the past 3 months, 8 analysts have published their opinion on Privia Health Group (NASDAQ:PRVA) stock. These analysts are typically employed by large Wall Street banks and tasked with...
Via
Benzinga
Canaccord Genuity Maintains Buy Rating for Privia Health Group: Here's What You Need To Know
August 25, 2022
Canaccord Genuity has decided to maintain its Buy rating of Privia Health Group (NASDAQ:PRVA) and raise its price target from $45.00 to $50.00. Shares of Privia Health Group are trading down 1.12% over...
Via
Benzinga
Why Amazon Shares Traded Lower; Here Are 74 Biggest Movers From Yesterday
August 23, 2022
Gainers Bright Minds Biosciences Inc. (NASDAQ: DRUG) shares jumped 72.8% to close at $2.16 on Monday as the stock continued to see momentum despite the company last week announcing it is not aware of...
Via
Benzinga
< Previous
1
2
3
4
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms Of Service
.